The present invention is directed to expression vectors comprising a polynucleotide that encodes a human telomerase reverse transcriptase (hTRT) protein, variant, or fragment. The present invention is also directed to host cells that comprise expression vectors comprising a polynucleotide that encodes...http://www.google.fr/patents/US20030044953?utm_source=gb-gplus-shareBrevet US20030044953 - Novel telomerase
Numéro de demande: 10/054,295 Numéro de publication: US 2003/0044953 A1 Date de dépôt: 18 janv. 2002 Brevet délivré: US6921664 ( Date de délivrance 26 juil. 2005)
